Clinical Trial Update: Zilver® PTX® in China [NA]

View source ↗

Summary

The Zilver PTX paclitaxel-coated nitinol stent trial in China for peripheral arterial disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Zilver PTX (paclitaxel-coated nitinol arterial stent)

Snippet

Sponsor: Cook Group Incorporated | Conditions: Peripheral Artery Disease | NA | Status: COMPLETED